$39.37
0.03% today
Nasdaq, Sep 16, 08:16 pm CET
ISIN
US8688731004
Symbol
SRDX

Surmodics Inc Stock price

$39.36
-0.66 1.65% 1M
+10.38 35.82% 6M
+3.01 8.28% YTD
+3.78 10.62% 1Y
-17.58 30.87% 3Y
-7.47 15.95% 5Y
+20.49 108.59% 10Y
Nasdaq, Closing price Fri, Sep 13 2024
+0.35 0.90%
ISIN
US8688731004
Symbol
SRDX
Sector

Key metrics

Market capitalization $561.55m
Enterprise Value $556.82m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.61
P/S ratio (TTM) P/S ratio 4.65
P/B ratio (TTM) P/B ratio 4.75
Revenue growth (TTM) Revenue growth -7.49%
Revenue (TTM) Revenue $120.82m
EBIT (operating result TTM) EBIT $-7.48m
Free Cash Flow (TTM) Free Cash Flow $-5.86m
Cash position $38.18m
EPS (TTM) EPS $-0.10
P/E forward negative
P/S forward 4.56
EV/Sales forward 4.52
Short interest 4.06%
Show more

Is Surmodics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Surmodics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Surmodics Inc forecast:

3x Hold
100%

Analyst Opinions

3 Analysts have issued a Surmodics Inc forecast:

Hold
100%

Financial data from Surmodics Inc

Assets
Jun '24
80 80
Cash 38 38
Claims 24 24
Inventories 15 15
Other current assets Other current assets Current assets 2.72 2.72
97 97
Property, plant and equipment 29 29
Financial assets - -
Intangible Assets 67 67
Other fixed assets Other assets Fixed assets 1.45 1.45
Total Assets 177 177
Liabilities
Jun '24
Equity 118 118
59 59
Current liabilities 20 20
Non-current liabilities 39 39
Total Capital 177 177

In millions USD.

Don't miss a Thing! We will send you all news about Surmodics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Surmodics Inc Stock News

Neutral
Business Wire
3 months ago
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced it has been awarded a group purchasing agreement for thrombectomy products with Premier, Inc. Effective June 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-nego...
Neutral
Accesswire
4 months ago
NEW ORLEANS, LA / ACCESSWIRE / May 30, 2024 / Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Neutral
PRNewsWire
4 months ago
NEW YORK , May 29, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Surmodics, Inc. (NASDAQ: SRDX) and its board of directors concerning the proposed acquisition of the company by GTCR. Stockholders will receive $43.00 for each share of Surmodics stock that they hold.
More Surmodics Inc News

Company Profile

SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Head office United States
CEO Gary Maharaj
Employees 376
Founded 1979
Website www.surmodics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today